Evolution of CT radiation dose in pediatric patients undergoing hybrid 2-[18F]FDG PET/CT between 2007 and 2021

OBJECTIVES: To evaluate the evolution of CT radiation dose in pediatric patients undergoing hybrid 2-[18F]fluoro-2-deoxy-D-glucose (2-[18F]FDG) PET/CT between 2007 and 2021.

METHODS AND MATERIALS: Data from all pediatric patients aged 0-18 years who underwent hybrid 2-[18F]FDG PET/CT of the body between January 2007 and May 2021 were reviewed. Demographic and imaging parameters were collected. A board-certified radiologist reviewed all CT scans and measured image noise in the brain, liver, and adductor muscles.

RESULTS: 294 scans from 167 children (72 females (43%); median age: 14 (IQR 10-15) years; BMI: median 17.5 (IQR 15-20.4) kg/m2) were included. CT dose index-volume (CTDIvol) and dose length product (DLP) both decreased significantly from 2007 to 2021 (both p < 0.001, Spearman's rho coefficients -0.46 and -0.35, respectively). Specifically, from 2007 to 2009 to 2019-2021 CTDIvol and DLP decreased from 2.94 (2.14-2.99) mGy and 309 (230-371) mGy*cm, respectively, to 0.855 (0.568-1.11) mGy and 108 (65.6-207) mGy*cm, respectively. From 2007 to 2021, image noise in the brain and liver remained constant (p = 0.26 and p = 0.06), while it decreased in the adductor muscles (p = 0.007). Peak tube voltage selection (in kilovolt, kV) of CT scans shifted from high kV imaging (140 or 120kVp) to low kV imaging (100 or 80kVp) (p < 0.001) from 2007 to 2021.

CONCLUSION: CT radiation dose in pediatric patients undergoing hybrid 2-[18F]FDG PET/CT has decreased in recent years equaling approximately one-third of the initial amount.

ADVANCES IN KNOWLEDGE: Over the past 15 years, CT radiation dose decreased considerably in pediatric patients undergoing hybrid imaging, while objective image quality may not have been compromised.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:96

Enthalten in:

The British journal of radiology - 96(2023), 1152 vom: 31. Dez., Seite 20220482

Sprache:

Englisch

Beteiligte Personen:

Skawran, Stephan [VerfasserIn]
Sartoretti, Thomas [VerfasserIn]
Gennari, Antonio G [VerfasserIn]
Schwyzer, Moritz [VerfasserIn]
Sartoretti, Elisabeth [VerfasserIn]
Treyer, Valerie [VerfasserIn]
Maurer, Alexander [VerfasserIn]
Huellner, Martin W [VerfasserIn]
Waelti, Stephan [VerfasserIn]
Messerli, Michael [VerfasserIn]

Links:

Volltext

Themen:

0Z5B2CJX4D
Fluorodeoxyglucose F18
Journal Article

Anmerkungen:

Date Completed 25.12.2023

Date Revised 25.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1259/bjr.20220482

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362475628